Headline News about MoonLake Immunotherapeutics - Class A Ordinary Shares
![](https://investorplace.com/wp-content/uploads/2023/01/hkd1600-3-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2023/06/26/wolfspeed_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2020/02/medicine-iv-drip.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/06/26/image30_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_12579.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for MoonLake
June 15, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
What 10 Analyst Ratings Have To Say About MoonLake
May 01, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Where MoonLake Stands With Analysts
March 20, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2020/07/medicine-1.jpg)
![](https://www.investors.com/wp-content/uploads/2019/09/Stock-drug-63-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://g.foolcdn.com/editorial/images/737539/lcid-vehicle.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/06/26/mltx.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/12/number-g8f03ffd27_1280.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/05/30/number-g8f03ffd27_1280.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/05/22/shutterstock_283469984.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/05/15/number-437928_1920.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/24/ideaya_biosciences_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/24/entrepreneur-1340649_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/10/short_squeeze3.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/20/image40.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/20/image_5.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/20/stock__chart_image.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/13/businessman-5669431_1920.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/06/charts-5669430_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/14/mltx_logo_light__a6509896c67a7794a6a99977958b1ed1.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2023
February 14, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.